Literature DB >> 22297422

Serological and bacteriological responses of water buffalo (Bubalus bubalis) vaccinated with two doses of Brucella abortus strain RB51 vaccine.

Anil Ramnanan1, Michael Diptee, Zinora Asgarali, Mervyn Campbell, Abiodun Adewale Adesiyun.   

Abstract

Thirty-two water buffalo (Bubalus bubalis) calves aged 6–10 months were used to evaluate serological responses to Brucella abortus strain RB51 (RB51) vaccination in a dose-response study and to compare the use of two selective media for the isolation of RB51. The animals were randomly divided into three treatment groups. Groups I-III received the recommended vaccine dose (RD) twice 4 weeks apart, RD twice 18 weeks apart and saline once, respectively. Lymph nodes were excised from the three groups and subjected to bacteriological examination to determine the frequency of detection of RB51. Pre- and post-vaccination blood samples were collected and tested for B. abortus antibodies using the buffered plate agglutination test (BPAT), complement fixation test (CFT), and dot-blot assay. Sera taken at all post-inoculation weeks (PIW) were negative for field strain B. abortus using the BPAT. Antibody responses to RB51 were demonstrated in all vaccinates but not in controls by CFT and dot-blot assay from 1 PIW up to 16 weeks following booster vaccination. The agreement for both assays was 80.7% and there was a linear interdependence with a Pearson's correlation coefficient value of 0.578. The frequency of isolation of RB51 from the two selective media used was not significantly different (P > 0.05).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297422     DOI: 10.1007/s11250-012-0086-4

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  23 in total

1.  Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion.

Authors:  Terry J Kreeger; Walter E Cook; William H Edwards; Philip H Elzer; Steven C Olsen
Journal:  J Wildl Dis       Date:  2002-01       Impact factor: 1.535

Review 2.  Diagnosis of brucellosis by serology.

Authors:  Klaus Nielsen
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

3.  Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle.

Authors:  F A Uza; L Samartino; G Schurig; A Carrasco; K Nielsen; R F Cabrera; H R Taddeo
Journal:  Vet Res Commun       Date:  2000-04       Impact factor: 2.459

4.  Isolation of Brucella abortus biovar 1 from cattle and water buffaloes on Trinidad.

Authors:  G T Fosgate; A A Adesiyun; D W Hird; S K Hietala; J Ryan
Journal:  Vet Rec       Date:  2002-08-31       Impact factor: 2.695

5.  Field validation of the use of RB51 as antigen in a complement fixation test to identify calves vaccinated with Brucella abortus RB51.

Authors:  R Adone; F Ciuchini; S Olsen
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.

Authors:  R Adone; F Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  The evaluation of tests.

Authors:  S W Martin
Journal:  Can J Comp Med       Date:  1977-01

8.  Evaluation of brucellosis RB51 vaccine for domestic water buffalo (Bubalus bubalis) in Trinidad.

Authors:  G T Fosgate; A A Adesiyun; D W Hird; W O Johnson; S K Hietala; G G Schurig; J Ryan; M D Diptee
Journal:  Prev Vet Med       Date:  2003-05-15       Impact factor: 2.670

9.  Comparison of serologic tests for detection of Brucella infections in cattle and water buffalo (Bubalus bubalis).

Authors:  Geoffrey T Fosgate; Abiodun A Adesiyun; David W Hird; Wesley O Johnson; Sharon K Hietala; Gerhardt G Schurig; Joseph Ryan
Journal:  Am J Vet Res       Date:  2002-11       Impact factor: 1.156

10.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.